Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease
Lori N. Eidson, George T. Kannarkat, Christopher J. Barnum, et al.
Journal of Neuroinflammation (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Inflammation and immune dysfunction in Parkinson disease
Malú G. Tansey, Rebecca L. Wallings, Madelyn C. Houser, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 11, pp. 657-673
Open Access | Times Cited: 781
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
Velma T. E. Aho, Madelyn C. Houser, Pedro A. B. Pereira, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 310
Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration
Sean K. Ryan, Matija Zelic, Yingnan Han, et al.
Nature Neuroscience (2022) Vol. 26, Iss. 1, pp. 12-26
Open Access | Times Cited: 203
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
Zheng Fan, Yuting Pan, Zhiyuan Zhang, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 169
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review
Emily Klann, Upuli Dissanayake, Anjela Gurrala, et al.
Frontiers in Aging Neuroscience (2022) Vol. 13
Open Access | Times Cited: 121
Immune system responses in Parkinson's disease: Early and dynamic
Malú G. Tansey, Marina Romero‐Ramos
European Journal of Neuroscience (2018) Vol. 49, Iss. 3, pp. 364-383
Open Access | Times Cited: 137
Biomarkers for Parkinson’s Disease: How Good Are They?
Tianbai Li, Weidong Le
Neuroscience Bulletin (2019) Vol. 36, Iss. 2, pp. 183-194
Open Access | Times Cited: 125
Exploring the “Multiple-Hit Hypothesis” of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat
Kristin L. Patrick, Samantha L. Bell, Chi G. Weindel, et al.
Frontiers in Cellular and Infection Microbiology (2019) Vol. 9
Open Access | Times Cited: 92
Silencing Alpha Synuclein in Mature Nigral Neurons Results in Rapid Neuroinflammation and Subsequent Toxicity
Matthew J. Benskey, Rhyomi C. Sellnow, Ivette M. Sandoval, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 89
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
Mary K. Herrick, Malú G. Tansey
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 69
Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases
Doortje Dekens, Ulrich Eisel, Leonie Gouweleeuw, et al.
Ageing Research Reviews (2021) Vol. 70, pp. 101414-101414
Open Access | Times Cited: 60
Update on CSF Biomarkers in Parkinson’s Disease
Eun Hae Kwon, Sabrina Tennagels, Ralf Gold, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 329-329
Open Access | Times Cited: 53
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
Milan Zimmermann, Kathrin Brockmann
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S183-S200
Open Access | Times Cited: 43
The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis
Frederieke Gigase, Emma Smith, Brett Collins, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 4, pp. 1502-1515
Closed Access | Times Cited: 35
Brain and Systemic Inflammation in De Novo Parkinson's Disease
Talene A. Yacoubian, Yu-Hua Fang, Adam Gerstenecker, et al.
Movement Disorders (2023) Vol. 38, Iss. 5, pp. 743-754
Open Access | Times Cited: 32
Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson's Disease”
Tiago F. Outeiro, Roy N. Alcalay, Angelo Antonini, et al.
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1127-1142
Open Access | Times Cited: 27
Inflammation as common link to progressive neurological diseases
Ana Dias-Carvalho, Susana I. Sá, Félix Carvalho, et al.
Archives of Toxicology (2023) Vol. 98, Iss. 1, pp. 95-119
Open Access | Times Cited: 26
Parkinson disease therapy: current strategies and future research priorities
Fabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 12, pp. 695-707
Closed Access | Times Cited: 10
Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
José A. Santiago, Virginie Bottero, Judith A. Potashkin
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 82
Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?
Marie‐Thérèse Armentero, Silvia Cerri, Fabio Blandini
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 61
Translocator Protein Ligand Protects against Neurodegeneration in the MPTP Mouse Model of Parkinsonism
Jing Gong, Éva M. Szegő, Andrei Leonov, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 19, pp. 3752-3769
Open Access | Times Cited: 56
Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series
Valerie Joers, Gunasingh Masilamoni, Doty Kempf, et al.
Neurobiology of Disease (2020) Vol. 144, pp. 105027-105027
Open Access | Times Cited: 52
Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10
Xiang Wang, Elvira Negrou, Michael T. Maloney, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 47
Immune-related biomarkers for Parkinson's disease
Ilham Y. Abdi, Simona S. Ghanem, Omar M. A. El‐Agnaf
Neurobiology of Disease (2022) Vol. 170, pp. 105771-105771
Open Access | Times Cited: 29
Peripheral Inflammatory Markers TNF-α and CCL2 Revisited: Association with Parkinson’s Disease Severity
Georgia Xiromerisiou, Chrysoula Marogianni, Ioannis C. Lampropoulos, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 264-264
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top